Literature DB >> 20633128

Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system.

Gabriel A Silva1.   

Abstract

Nanotechnology is the science and engineering concerned with the design, synthesis, and characterization of materials and devices that have a functional organization in at least one dimension on the nanometer (i.e., one billionth of a meter) scale. The potential impact of bottom up self-assembling nanotechnology, custom made molecules that self-assemble or self-organize into higher ordered structures in response to a defined chemical or physical cue, and top down lithographic type technologies where detail is engineered at smaller scales starting from bulk materials, stems from the fact that these nanoengineered materials and devices exhibit emergent mesocale and macroscale chemical and physical properties that are often different than their constituent nanoscale building block molecules or materials. As such, applications of nanotechnology to medicine and biology allow the interaction and integration of cells and tissues with nanoengineered substrates at a molecular (i.e., subcellular) level with a very high degree of functional specificity and control. This review considers applications of nanotechnology aimed at the neuroprotection and functional regeneration of the central nervous system (CNS) following traumatic or degenerative insults, and nanotechnology approaches for delivering drugs and other small molecules across the blood-brain barrier. It also discusses developing platform technologies that may prove to have broad applications to medicine and physiology, including some being developed for rescuing or replacing anatomical and/or functional CNS structures.

Entities:  

Mesh:

Year:  2010        PMID: 20633128     DOI: 10.1111/j.1749-6632.2009.05361.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

Review 2.  Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Steffen E Storck; Claus U Pietrzik
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

3.  Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Int Drug Discov       Date:  2011 Jun-Jul

Review 4.  Etiology and pathogenesis of late-onset Alzheimer's disease.

Authors:  Brian J Balin; Alan P Hudson
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

5.  Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles.

Authors:  Zhijun Liu; Fang Zhang; Gar Yee Koh; Xin Dong; Javoris Hollingsworth; Jian Zhang; Paul S Russo; Peiying Yang; Rhett W Stout
Journal:  Anticancer Drugs       Date:  2015-02       Impact factor: 2.248

6.  TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease.

Authors:  Matthew J Haney; Natalia L Klyachko; Emily B Harrison; Yuling Zhao; Alexander V Kabanov; Elena V Batrakova
Journal:  Adv Healthc Mater       Date:  2019-04-18       Impact factor: 9.933

7.  Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.

Authors:  Andressa Bernardi; Rudimar L Frozza; André Meneghetti; Juliana B Hoppe; Ana Maria O Battastini; Adriana R Pohlmann; Sílvia S Guterres; Christianne G Salbego
Journal:  Int J Nanomedicine       Date:  2012-09-13

8.  Engineered nanomaterials: exposures, hazards, and risk prevention.

Authors:  Robert A Yokel; Robert C Macphail
Journal:  J Occup Med Toxicol       Date:  2011-03-21       Impact factor: 2.646

9.  Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines.

Authors:  Tiago dos Santos; Juan Varela; Iseult Lynch; Anna Salvati; Kenneth A Dawson
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

10.  Tracking of magnetite labeled nanoparticles in the rat brain using MRI.

Authors:  Naira P Martínez Vera; Reinhold Schmidt; Klaus Langer; Iavor Zlatev; Robert Wronski; Ewald Auer; Daniel Havas; Manfred Windisch; Hagen von Briesen; Sylvia Wagner; Julia Stab; Motti Deutsch; Claus Pietrzik; Franz Fazekas; Stefan Ropele
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.